Our study further confirms the oncogenic role of METTL3 in GC and indicates that METTL3 promotes the progression of GC through recruiting IGF2BP2 to stabilize SLC38A7 mRNA stability. The gene discussed is SLC38A7; the disease is gastric cancer.